Similar articles

• Effects of mazindol on the in vitro uptake of monoamines by the rat brain [proceedings].

  Mireylees SE, Sugrue MF. Mireylees SE, et al. Br J Pharmacol. 1978 Mar;62(3):404P-405P. Br J Pharmacol. 1978. PMID: 638335 Free PMC article. No abstract available.
• Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices.

  Heikkila RE, Cabbat FS, Mytilineou C. Heikkila RE, et al. Eur J Pharmacol. 1977 Oct 15;45(4):329-33. doi: 10.1016/0014-2999(77)90271-0. Eur J Pharmacol. 1977. PMID: 923643
• Studies on maxindol as an amine uptake inhibitor.

  Fuller RW, Snoddy HD, Wong DT, Bymaster FP. Fuller RW, et al. Commun Psychopharmacol. 1978;2(3):223-30. Commun Psychopharmacol. 1978. PMID: 699537 No abstract available.
• [Behavioral disorders: possible correlation with biogenic cerebral amines].

  Palermo Neto J, Carvalho FV. Palermo Neto J, et al. Rev Paul Med. 1974 Mar;83(3):137-44. Rev Paul Med. 1974. PMID: 4614362 Review. Portuguese. No abstract available.
• The mechanism of action of fenfluramine.

  Garattini S, Buczko W, Jori A, Samanin R. Garattini S, et al. Postgrad Med J. 1975;51 Suppl 1:27-35. Postgrad Med J. 1975. PMID: 768968 Review. No abstract available.